Keywords
Supplementation
Vitamin E
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To explore available clinical data on vitamin E supplementation in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). Methods: This study consists of an integrative literature review conducted through a comprehensive search of articles in electronic databases, including PubMed, Medline, and Science Direct. The search was performed using combinations of English keywords such as "Non-Alcoholic Fatty Liver Disease," "supplementation," "treatment," and "vitamin E." Article screening was based on the publication date, covering the last 5 years of research on the topic of NAFLD treatment with vitamin E. Results: After conducting the article search across various selected databases, 6 publications were found in ScienceDirect, 191 in Medline, and 31 in PubMed, totaling 222 publications. Applying the criteria established in this study, we identified 13 articles suitable for this review. Treatment with vitamin E supplementation has been shown to reduce and/or reverse the NAFLD condition. Final considerations: Faced with the lack of more effective therapeutic options, vitamin E emerges as a safe and accessible alternative, offering a promising outlook for patients affected by NAFLD.
References
ALAM S, et al. Effect of telmisartan and vitamin E on liver histopathology with non‐alcoholic steatohepatitis: A randomized, open‐label, noninferiority trial. JGH Open, 2020; 4(4): 663-669.
BAI Y, et al. Aerobic exercise and vitamin E improve high-fat diet-induced NAFLD in rats by regulating the AMPK pathway and oxidative stress. European Journal of Nutrition, 2023; 1-12.
CHEN BR e PAN CQ. Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease. Clinics and Research in Hepatology and Gastroenterology, 2022; 46(1): 101755.
DELLI BOVI AP, et al. Oxidative stress in non-alcoholic fatty liver disease. An updated mini review. Frontiers in medicine, 2021; 8: 165.
DE OLIVEIRA LB e DOS SANTOS TORRES MR. Prevalência de doença hepática gordurosa não alcoólica apontada por ultrassonografia em pacientes com diabetes tipo 2 hospitalizados. Revista de Ciências Médicas e Biológicas, 2021; 20(2): 307-313.
EVANS HM e BISHOP KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science, 1922; 56(1458): 650-651.
FRANK J, et al. Sex differences in the inhibition of γ-tocopherol metabolism by a single dose of dietary sesame oil in healthy subjects. The American journal of clinical nutrition, 2008; 87(6): 1723-1729.
GIGI E, et al. The clinical significance of transient elastografy and cap in the diagnosis and surveillance of non-alcoholic fatty liver disease. Journal of Hepatology, 2023; 78: S730.
GREBENSTEIN N, et al. α‐Tocopherol transfer protein is not required for the discrimination against γ‐tocopherol in vivo but protects it from side‐chain degradation in vitro. Molecular nutrition & food research, 2014; 58(5): 1052-1060.
HASENOUR CM, et al. Vitamin E does not prevent Western diet-induced NASH progression and increases metabolic flux dysregulation in mice. Journal of Lipid Research, 2020; 61(5): 707-721.
JARVIS H, et al. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. PLoS medicine, 2020; 17(4): 1003100.
KAYDEN HJ e TRABER MG. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. Journal of lipid research, 1993; 34(3): 343-358.
KEDARISETTY CK, et al. Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis - A randomized pilot study. Indian Journal of Gastroenterology, 2021; 40: 41-49.
LAHMI A, et al. Comparative effects of thymol and vitamin E on nonalcoholic fatty liver disease in male Wistar rats. Brazilian Journal of Biology, 2023; 84.
MOSCA A, et al. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD. Digestive and Liver Disease, 2021; 53(9): 1154-1158.
OTT-FONTES PR, et al. Comparison of the severity of non-alcoholic fatty liver disease in diabetic and non-diabetic obese patients. Revista do Colégio Brasileiro de Cirurgiões, 2020; 47.
PANERA N, et al. Combination treatment with hydroxytyrosol and vitamin e improves nafld-related fibrosis. Nutrients, 2022; 14(18): 3791.
PODSZUN MC, et al. Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis. Redox Biology, 2020; 37: 101710.
POULOS JE, et al. The effects of vitamin E, silymarin and carnitine on the metabolic abnormalities associated with nonalcoholic liver disease. Journal of Dietary Supplements, 2022; 19(3): 287-302.
PRESA N, et al. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019; 1865(1): 14-25.
RIVERA J, et al. SAT-460 - Evaluation of serum biomarkers for the diagnosis of non-alcoholic fatty liver disease in the general population: a cross-sectional Spanish population-based study, Journal of Hepatology, 2023; 78(1): S693-S694.
SCORLETTI E, et al. Dietary vitamin E intake is associated with a reduced risk of developing digestive diseases and nonalcoholic fatty liver disease. Official journal of the American College of Gastroenterology| ACG, 2022; 117(6): 927-930.
VOGLI S, et al. The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis. Nutrients, 2023; 15(17): 3733.
YODOSHI T, et al. Identifying predictors of response to vitamin E for the treatment of pediatric nonalcoholic steatohepatitis. Journal of parenteral and Enteral Nutrition, 2020; 44(7): 1301-1307.
ZHAO B, et al. Study on the mechanism of vitamin E alleviating non-alcoholic fatty liver function based on non-targeted metabolomics analysis in rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 2023; 1-9.